
Bladder Cancer Breakthroughs
A Global Perspective on Diagnosis, Treatment, and Patient Care
Academic Press
Will be published approx. on 1. January 2026
Book
Paperback/Softback
220 pages
978-0-443-36632-1 (ISBN)
Description
Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care is a groundbreaking scientific resource that delves into the latest advancements in the diagnosis and treatment of bladder cancer, a prevalent malignancy affecting hundreds of thousands worldwide. This meticulously curated volume brings together contributions from leading scientists and healthcare professionals from around the globe, providing a comprehensive overview of contemporary understanding and innovative strategies in managing this complex disease. Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care is not merely a collection of research findings; it is a vital resource that fosters a holistic perspective on patient-centered care. By synthesizing clinical expertise and evidence-based practices, this book aims to empower healthcare providers with the knowledge and tools needed to improve outcomes for individuals living with bladder cancer, ultimately contributing to the global fight against this challenging disease. This book serves as an essential guide for healthcare providers, including physicians, oncologists, immunologists, pharmacists, and physical therapists, striving to enhance patient care and treatment outcomes
More details
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
Professional and scholarly
Dimensions
Height: 235 mm
Width: 191 mm
Thickness: 22 mm
Weight
450 gr
ISBN-13
978-0-443-36632-1 (9780443366321)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions

Bhupendra G. Prajapati | Devesh U. Kapoor | Abdullah F. AlAsmari
Bladder Cancer Breakthroughs
A Global Perspective on Diagnosis, Treatment, and Patient Care
E-Book
01/2026
Elsevier
€162.99
Available for download
Persons
Dr. Bhupendra Gopalbhai Prajapati is a Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India. He is also acting as Adjunct Professor at Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Thailand. With over 22 years of experience in academia, research, and industry, he specializes in lipid-based formulations, nano/microparticulate drug delivery, and bioavailability enhancement. A recipient of several prestigious awards including the AICTE Young Teacher Award and Ganpat University's Staff Excellence honors, Dr. Prajapati has published over 350 research/review papers, and has contributed to more than 170 book chapters. He actively mentors Ph.D. and PG scholars and serves as editor or section editor for several international publications in pharmaceutical sciences. Dr. Devesh U. Kapoor is a Professor at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, where he has served since September 2010. He holds a B.Pharm from the University of Rajasthan and an M.Pharm in Pharmaceutics from Rajasthan University of Health Sciences, along with a PhD in pharmaceutical sciences. With 14 years of teaching and administrative experience, Dr. Kapoor has authored over 35 research and review articles in esteemed national and international journals and contributed to several books published by Elsevier, Bentham Science, MDPI, Springer, and Wiley. His research focuses on osmotic drug delivery systems, solid lipid nanoparticles, and microspheres. He has received significant grants for organizing national seminars and faculty development programs. Dr. Kapoor holds three design patents and has delivered over 10 expert talks at various national conferences. He is currently the editor of three international books with prominent publishers.
Dr. Abdullah AlAsmari was graduated from King Saud University (KSU) with a B.S. in Pharmaceutical Sciences in 2011. In 2013, Dr. AlAsmari joined Auburn University (AU), Harrison School of Pharmacy department of Drug Discovery and Development (DDD) to pursue his PhD under supervision of Dr. Jianzhong Shen and Dr. Amin. In 2017, Dr. AlAsmari returned to KSU with PhD degree and became an assistant professor in the department of Pharmacology & Toxicology. Now he has been promoted as Associate Professor and serving as Vice Dean for Programs and Initiatives at Graduate School at KSU. He is currently working on different funded projects, which aim to induce cardioprotection against different mechanisms that can induce cardiac damage. His research area includes: Cardiovascular Diseases, Mechanisms of cardiotoxicity induced by different anti-cancer drugs. Dr Abdullah has published more than 150 articles in different reputed and peer reviewed journals and several book chapters.
Dr. Abdullah AlAsmari was graduated from King Saud University (KSU) with a B.S. in Pharmaceutical Sciences in 2011. In 2013, Dr. AlAsmari joined Auburn University (AU), Harrison School of Pharmacy department of Drug Discovery and Development (DDD) to pursue his PhD under supervision of Dr. Jianzhong Shen and Dr. Amin. In 2017, Dr. AlAsmari returned to KSU with PhD degree and became an assistant professor in the department of Pharmacology & Toxicology. Now he has been promoted as Associate Professor and serving as Vice Dean for Programs and Initiatives at Graduate School at KSU. He is currently working on different funded projects, which aim to induce cardioprotection against different mechanisms that can induce cardiac damage. His research area includes: Cardiovascular Diseases, Mechanisms of cardiotoxicity induced by different anti-cancer drugs. Dr Abdullah has published more than 150 articles in different reputed and peer reviewed journals and several book chapters.
Editor
Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, India
Professor, Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, India
KIng Saud University, Saudi Arabia
Content
1. Epidemiology and risk factors of bladder cancer
2. Diagnosis approaches for bladder cancer
3. Role of hydrogel in bladder cancer treatment
4. Role of Nanoparticles in bladder cancer management
5. Role of Quantum dots in bladder cancer management
6. Nanomaterial based biomarkers in bladder cancer management
7. Role of nanorods in bladder cancer management
8. Role of liposomes in bladder cancer management
9. Role of artificial intelligence in bladder cancer management
10. Role of nanocomposite for bladder cancer management
11. Targeting treatment of bladder cancer employing aptamer conjugates
12. Surgical interventions for bladder cancer management
13. Image guided radiotherapy for bladder cancer management
14. Role of gene sequencing in bladder cancer
15. Addressing and overcoming resistance in bladder cancer treatment
2. Diagnosis approaches for bladder cancer
3. Role of hydrogel in bladder cancer treatment
4. Role of Nanoparticles in bladder cancer management
5. Role of Quantum dots in bladder cancer management
6. Nanomaterial based biomarkers in bladder cancer management
7. Role of nanorods in bladder cancer management
8. Role of liposomes in bladder cancer management
9. Role of artificial intelligence in bladder cancer management
10. Role of nanocomposite for bladder cancer management
11. Targeting treatment of bladder cancer employing aptamer conjugates
12. Surgical interventions for bladder cancer management
13. Image guided radiotherapy for bladder cancer management
14. Role of gene sequencing in bladder cancer
15. Addressing and overcoming resistance in bladder cancer treatment